Innovex executive sells 10,750 shares at $28

Innovex International, Inc. executive Mark Reddout, President of North America, reported an open-market sale of 10,750 shares of common stock at $28.00 per share.

Rhea-AI Filing Summary

Innovex International, Inc. executive Mark Reddout, President of North America, reported an open-market sale of 10,750 shares of common stock at $28.00 per share. The sale was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on March 2, 2026.

After this transaction, Reddout continues to hold 134,312 shares of Innovex common stock directly, so he retains a significant ongoing stake in the company despite the sale being a net reduction in his holdings.

Insider Trade Summary 10b5-1

Net Seller: 10,750 shares

Net Sell 1 txn

Insider Reddout Mark

Role President of North America

Sold 10,750 shs ($301K)

Type	Security	Shares	Price	Value
Sale	Common Stock	10,750	$28.00	$301K

Holdings After Transaction: Common Stock — 134,312 shares (Direct)

Footnotes (2)

1. F1. Sales pursuant to a Rule 10b5-1 plan adopted on March 2, 2026.
2. F2. All shares were sold at the price in column 4.

Key Figures

Shares sold: 10,750 shares Sale price: $28.00 per share Shares held after sale: 134,312 shares

3 metrics

Shares sold 10,750 shares Open-market sale on June 2, 2026

Sale price $28.00 per share Price for all shares in this transaction

Shares held after sale 134,312 shares Direct holdings following the transaction

Key Terms

Rule 10b5-1 plan, open-market sale, Common Stock

3 terms

Rule 10b5-1 plan regulatory

"Sales pursuant to a Rule 10b5-1 plan adopted on March 2, 2026."

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

open-market sale financial

"transaction_action is described as an open-market sale of Common Stock."

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Common Stock financial

"The transaction involved Common Stock as the non-derivative security title."

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Innovex International (INVX) report for Mark Reddout?

Innovex International reported that executive Mark Reddout sold 10,750 shares of common stock at $28.00 per share. This was an open-market sale and he continues to hold 134,312 shares directly after the transaction.

Was the INVX insider sale by Mark Reddout under a Rule 10b5-1 plan?

Yes. The filing states that Mark Reddout’s sale was made under a Rule 10b5-1 trading plan adopted on March 2, 2026. Such plans pre-schedule trades, making the timing more routine and less discretionary.

How many Innovex (INVX) shares does Mark Reddout hold after this Form 4 sale?

Following the reported sale, Mark Reddout directly holds 134,312 shares of Innovex common stock. This indicates that, even after selling 10,750 shares, he maintains a substantial remaining equity position in the company.

What price did Mark Reddout receive per share in the Innovex (INVX) sale?

All 10,750 shares were sold at $28.00 per share, according to the Form 4. A footnote clarifies that every share in this transaction was sold at the same price listed in the transaction column.

What type of transaction was reported in the Innovex (INVX) Form 4 filing?

The Form 4 shows a non-derivative open-market sale of common stock by executive Mark Reddout. The transaction code is “S,” which the filing describes as a sale in an open market or private transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/03/2026 - 06:30 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Reddout Mark

(Last) (First) (Middle)

C/O INNOVEX INTERNATIONAL, INC.

19120 KENSWICK DRIVE

(Street)

HUMBLE TEXAS 77338

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Innovex International, Inc. [ INVX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President of North America

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/02/2026		S		10,750(1)	D	$28(2)	134,312	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Sales pursuant to a Rule 10b5-1 plan adopted on March 2, 2026.

2. All shares were sold at the price in column 4.

	/s/ Matt Steinheider, Attorney-in-Fact for Mark Reddout	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)